Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC005 in Adolescent Subjects With Severe Alopecia Areata
NCT07762443Phase 1Recruiting
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of VC-005 in alopecia areata (2 arms), sponsored by Jiangsu Vcare PharmaTech Co., Ltd. Primary endpoints: Area Under the Curve From Time Zero to Last Quantifiable Concentration at Day 28 and Peak Plasma Concentration at Day 28. Started Sep 2026; status: recruiting.
02
Drugs
VC-005
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07762443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07762443.